VendorMark said:

Denials are usually procedural rather than clinical, and the order that works reflects that.

VendorMark said:

...my insurance denied cost and coverage coverage because...

Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:

1. Document medical necessity (BMI, comorbidities, failed alternatives)
2. Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
3. Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
4. Request peer-to-peer review between your doctor and the plan's medical director
5. File external appeal with your state insurance department if internal appeal fails

Don't accept the first denial. The appeal process exists for a reason.

VendorMark said:

Denials are usually procedural rather than clinical, and the order that works reflects that.

This is where I part company with the consensus forming above. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

DataDave said:

The affordability discussion here usually stops at individual tactics.

Financial impact of cost and coverage weight loss beyond medication cost:

• Groceries: SAVED $278/month (eating less)
• Restaurants: SAVED $208/month (fewer meals out)
• Alcohol: SAVED $158/month (stopped drinking)
• Life insurance: Premium REDUCED by $48/month (lower BMI)
• Copays: SAVED $78/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

LarryQC_SD said:

VendorMark said: ...my insurance denied cost and coverage coverage because...

Same experience, arrived at from the opposite direction. The detail I would add is minor and it is already implied above.